Polatuzumab Vedotin in Combination with Bendamustine Plus Rituximab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Our Experience


Darcin T., Yigenoglu T. N., Sahin D., Bakirtas M., Basci S., Merdin A., ...More

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, vol.19, 2019 (SCI-Expanded) identifier